Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methamphetamine abuse: issues for special populations.

T E Freese1, J Obert, A Dickow

  • 1UCLA Integrated Substance Abuse Programs, UCLA/Matrix Coordinating Center for the CSAT Methamphetamine Treatment Project, Los Angeles, California, USA. tefreese@ix.netcom.com

Journal of Psychoactive Drugs
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIDS vaccines: is older better?

Science (New York, N.Y.)·1992
Same author

AIDS vaccines. Trials set in high-risk populations.

Science (New York, N.Y.)·1992
Same author

Dingell rips Healy for 'obstructionism'.

Science (New York, N.Y.)·1992
Same author

Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release.

Lancet (London, England)·1992
Same author

Pediatric AIDS vaccine trials set.

Science (New York, N.Y.)·1992
Same author

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.

The Journal of antimicrobial chemotherapy·1992
Same journal

Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study.

Journal of psychoactive drugs·2026
Same journal

Cannabis-Induced Persistent Perceptual Disturbances: A Clinical Characterization Study of Multimodal Sensory Symptoms in 13 Patients.

Journal of psychoactive drugs·2026
Same journal

Specialist Inpatient Detoxification from Gabapentinoids: Clinical and Demographic Characteristics and Predictors of Outcome.

Journal of psychoactive drugs·2026
Same journal

Urine Prevalence of Psychoactive Substances, Nicotine Exposure and Associated Factors Among Commercial Drivers. An Exploratory Study.

Journal of psychoactive drugs·2026
Same journal

Latent Clusters of Peer Behaviors in Childhood and Relevance for Understanding Substance Use in Early Adolescence.

Journal of psychoactive drugs·2026
Same journal

Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.

Journal of psychoactive drugs·2026
See all related articles

Methamphetamine abuse treatment programs are being compared to usual care. This study explores barriers and strategies for diverse populations, including rural and Native Americans, and gay and bisexual males.

Area of Science:

  • Addiction Medicine
  • Public Health
  • Sociology

Background:

  • Methamphetamine (MA) abuse is a persistent issue in the western United States, recently escalating to epidemic proportions in certain areas and demographics.
  • Effective treatments for MA dependence are urgently needed.
  • The Center for Substance Abuse Treatment (CSAT) initiated a multisite Methamphetamine Treatment Program (MTP) to address this need.

Purpose of the Study:

  • To compare the Matrix Model treatment program for MA with standard treatments.
  • To examine treatment access and completion issues for diverse special populations affected by MA dependence.
  • To identify and present strategies for overcoming identified barriers.

Main Methods:

  • A multisite study comparing the Matrix Model to treatment as usual.

Related Experiment Videos

  • Involved seven community-based clinics in California, Montana, and Hawaii.
  • Analysis focused on clients within the Methamphetamine Treatment Program (MTP).
  • Main Results:

    • The study examined specific populations including rural Americans, Native Americans, Native Hawaiians, gay and bisexual males, and drug court participants.
    • Cultural, geographic, and situational barriers to accessing and completing treatment were identified.
    • Strategies to overcome these barriers were presented.

    Conclusions:

    • Understanding and addressing diverse barriers is crucial for effective methamphetamine dependence treatment.
    • Tailored strategies are necessary to improve treatment engagement and completion rates for vulnerable populations.
    • The findings inform the development of more accessible and culturally relevant addiction treatment interventions.